Comparing two types of ketamine for stubborn depression
Treatments studied
Part of Mental health clinical trials.
This study compares two forms of ketamine to see which works better for depression that hasn't improved with at least two other antidepressants. If you've tried multiple antidepressants without success, this trial might help find a more effective treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult aged 18 or older.
- You have depression that hasn't responded to at least two different antidepressant medications taken at the right dose and for enough time.
- Your doctor has confirmed that you are a good candidate for ketamine treatment.
- You are able to give written permission to join the study.
- Your depression severity score is at least 20 on a standard depression rating scale (MADRS) at the start of the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two forms of ketamine—given by IV or as a nasal spray—in people with major depression that hasn't improved after trying at least two other antidepressants. The goal is to see which treatment works better.
This trial tests whether a combination of ketamine (given through an IV) and talk therapy can help people with depression that hasn't responded to other treatments. If you have tried multiple antidepressants and therapy without success, this study may offer a new option.
This study tests whether a single dose of ketamine can change brain wave patterns (called gamma oscillations) in people with treatment-resistant depression. Researchers want to see if these brain waves can predict who will feel better after treatment.
This trial tests whether adding ketamine to electroconvulsive therapy (ECT) works better than ECT alone for people with depression that hasn't improved with at least two different antidepressants. It may offer a new option for those who have not found relief from standard treatments.
This study compares two ways of using ketamine with ECT (electroconvulsive therapy) in people with treatment-resistant depression. It aims to find whether a higher-dose ketamine approach, with extra rescue measures, works better or more safely.
This study tests whether esketamine, a nasal spray for depression, can help adults whose depression has not improved with at least two other antidepressants. Participants continue their current treatment while receiving esketamine.
Hear when a new Treatment Resistant Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.